Nymox Pharmaceutical Stock Forecast, Price & News

Nymox Pharmaceutical (NASDAQ:NYMX) Frequently Asked Questions

How has Nymox Pharmaceutical's stock price been impacted by Coronavirus (COVID-19)?

Nymox Pharmaceutical's stock was trading at $2.29 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NYMX stock has decreased by 36.7% and is now trading at $1.45.
View which stocks have been most impacted by COVID-19.

When is Nymox Pharmaceutical's next earnings date?

Nymox Pharmaceutical is scheduled to release its next quarterly earnings announcement on Monday, April 4th 2022.
View our earnings forecast for Nymox Pharmaceutical.

How were Nymox Pharmaceutical's earnings last quarter?

Nymox Pharmaceutical Co. (NASDAQ:NYMX) posted its earnings results on Friday, November, 12th. The biopharmaceutical company reported ($0.04) earnings per share (EPS) for the quarter.
View Nymox Pharmaceutical's earnings history.

Who are Nymox Pharmaceutical's key executives?

Nymox Pharmaceutical's management team includes the following people:

• Paul Averback, Chairman, President & Chief Executive Officer
• Randall J. Lanham, COO, Secretary, Director & General Counsel
• Erik Danielsen, Chief Financial Officer
• Russell I. Thomson, Vice President-Quality & Regulatory Affairs

Who are some of Nymox Pharmaceutical's key competitors?

Some companies that are related to Nymox Pharmaceutical include Alpha Teknova (TKNO), Quotient (QTNT), Lucira Health (LHDX), MyMD Pharmaceuticals (MYMD), OncoCyte (OCX), VolitionRx (VNRX), Aspira Women's Health (AWH), Achieve Life Sciences (ACHV), ImmuCell (ICCC), Biomerica (BMRA), Navidea Biopharmaceuticals (NAVB), ARCA biopharma (ABIO), Trinity Biotech (TRIB), StageZero Life Sciences (SZLSF) and StageZero Life Sciences (GNWSF).
View all of NYMX's competitors.

What other stocks do shareholders of Nymox Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nymox Pharmaceutical investors own include Quantum (QTM), Rocket Pharmaceuticals (RCKT), Biocept (BIOC), TherapeuticsMD (TXMD), Catalyst Pharmaceuticals (CPRX), MEI Pharma (MEIP), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), Synergy Pharmaceuticals (SGYP) and CTI BioPharma (CTIC).

What is Nymox Pharmaceutical's stock symbol?

Nymox Pharmaceutical trades on the NASDAQ under the ticker symbol "NYMX."

Who are Nymox Pharmaceutical's major shareholders?

Nymox Pharmaceutical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Patriot Financial Group Insurance Agency LLC (0.03%).
View institutional ownership trends for Nymox Pharmaceutical.

Which major investors are selling Nymox Pharmaceutical stock?

NYMX stock was sold by a variety of institutional investors in the last quarter, including Patriot Financial Group Insurance Agency LLC.
View insider buying and selling activity for Nymox Pharmaceutical or view top insider-selling stocks.

How do I buy shares of Nymox Pharmaceutical?

Shares of NYMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nymox Pharmaceutical's stock price today?

One share of NYMX stock can currently be purchased for approximately $1.45.

How much money does Nymox Pharmaceutical make?

Nymox Pharmaceutical has a market capitalization of $122.52 million. The biopharmaceutical company earns $-11.74 million in net income (profit) each year or ($0.15) on an earnings per share basis.

How many employees does Nymox Pharmaceutical have?

Nymox Pharmaceutical employs 3 workers across the globe.

What is Nymox Pharmaceutical's official website?

The official website for Nymox Pharmaceutical is www.nymox.com.

Where are Nymox Pharmaceutical's headquarters?

Nymox Pharmaceutical is headquartered at BAY & DEVEAUX STREETS, NASSAU C5, H4M 2V2.

How can I contact Nymox Pharmaceutical?

Nymox Pharmaceutical's mailing address is BAY & DEVEAUX STREETS, NASSAU C5, H4M 2V2. The biopharmaceutical company can be reached via phone at (800) 936-9669, via email at [email protected], or via fax at 514-332-2227.